Special accreditation for the 2024 High-Level Meeting on Antimicrobial Resistance (AMR)
Recalling its resolution 76/257 of 29 March 2022, entitled “Elevating pandemic prevention, preparedness and response to the highest level of political leadership”, in which it decided to hold a high-level meeting in 2024 on antimicrobial resistance, the General Assembly requested the President of the General Assembly to draw up a list of relevant stakeholder organizations.
The High-level Meeting will be convened as outlined in A/RES/78/269.**
In order to participate in the high-level event, the following categories of relevant organizations that are not in consultative status with ECOSOC must express interest here and must apply for special accreditation.
- Non-governmental organizations
- Civil society organizations
- Academic institutions
- Private sector
The Application for special accreditation closes on 28 June 2024 at 23:59 [EDT].
Please Note:
* Application for special accreditation must be submitted on behalf of the organization, not an individual. Please see the information on the Special Accreditation here.
* Stakeholder applications will be approved by United Nations (UN) Member States, in accordance with the relevant General Assembly Resolution. The name of the organization and country will be shared with the UN Member States, and other information, including but not limited to the homepage may also be shared if requested.
* If you do not already have an Indico account, please create one before proceeding with your application. Please find the user guide on creating the account here.
**
The one-day high-level meeting on antimicrobial resistance to be convened by the President of the General Assembly shall be held at United Nations Headquarters in New York on 26 September 2024 during the general debate of the Assembly at its seventy-ninth session, from 10 a.m. to 6 p.m., and shall consist of an opening segment, a plenary segment for general discussion, two multi-stakeholder panels and a brief closing segment;
The overall theme of the high-level meeting will be “Investing in the present and securing our future together: accelerating multisectoral global, regional and national actions to address antimicrobial resistance”.
The opening segment, to be held from 10 to 10.45 a.m., will feature statements by the President of the General Assembly, the President of the Economic and Social Council, the Secretary-General, the Director General of the World Health Organization, the Director General of the Food and Agriculture Organization of the United Nations, the Executive Director of the United Nations Environment Programme, the Director General of the World Organisation for Animal Health, the President of the World Bank, a representative of the Global Leaders Group on Antimicrobial Resistance, as well as a person affected by antimicrobial resistance, selected in consultation with Member States by the President of the General Assembly and giving due consideration to gender balance and geographical representation.
The plenary segment, to be held from 10.45 a.m. to 5.30 p.m., will comprise statements by Member States and observers of the General Assembly; a list of speakers will be established in accordance with established practices of the Assembly, and the time limits for these statements will be three minutes for individual delegations and five minutes for statements made on behalf of a group of States.
The closing segment, to be held from 5.30 to 6 p.m., will comprise summaries of the multi-stakeholder panels and concluding remarks by the President of the General Assembly and a representative of the Global Leaders Group on Antimicrobial Resistance, as well as a person affected by antimicrobial resistance.
The organizational arrangements for the two multi-stakeholder panels will be as follows:
(a) Two multi-stakeholder panels will be held in parallel to the plenary segment, one from 11 a.m. to 1 p.m. and the other from 3 to 5 p.m.;
(b) The multi-stakeholder panels will address the following themes:
Panel 1: Addressing the urgent global risk of antimicrobial resistance across the human, animal, plant and environmental sectors through equity, access, building awareness and innovation;
Panel 2: Addressing human health, animal health, agrifood systems and protecting the environment to tackle antimicrobial resistance, through surveillance, capacity-building, sustainable resources, financing and investment;
(c) Each of the two multi-stakeholder panels will be co-chaired by two representatives, one from a developed country and one from a developing country, to be appointed by the President of the General Assembly from among the Heads of State or Government attending the high-level meeting, in consultation with Member States, taking into account gender balance, level of development and geographical representation.
